Maxifed Tr
NDC Package 58605-106-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Maxifed Tr is do not exceed recommended dosage.Adults and children 12 years of age and over:2 tablets every 4-6 hours, not to exceed 8 tablets in 24 hours, or as directed by a doctorChildren 6 to under 12 years of age:1 tablet every 4-6 hours, not to exceed 4 tablets in 24 hours, or as directed by a doctorChildren under 6 years of age:Consult a doctor. Marketed by Mcr American Pharmaceuticals, Inc., this product is identified by NDC 58605-106 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
58605-106-01
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
58605-106
11-Digit Billing Format
58605010601
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1099719 - pseudoephedrine HCl 30 MG / triprolidine HCl 1.25 MG Oral Tablet
  • RxCUI: 1099719 - pseudoephedrine hydrochloride 30 MG / triprolidine hydrochloride 1.25 MG Oral Tablet

Clinical Specifications

Proprietary Name
Maxifed Tr
Dosage Form
-
Usage Information
Do not exceed recommended dosage.Adults and children 12 years of age and over:2 tablets every 4-6 hours, not to exceed 8 tablets in 24 hours, or as directed by a doctorChildren 6 to under 12 years of age:1 tablet every 4-6 hours, not to exceed 4 tablets in 24 hours, or as directed by a doctorChildren under 6 years of age:Consult a doctor.

Regulatory & Marketing

Labeler Name
Mcr American Pharmaceuticals, Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-01-2020
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58605-106-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Maxifed Tr, labeled by Mcr American Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mcr American Pharmaceuticals, Inc. on August 01, 2020. The current certification is valid through December 31, 2021.

How is this Mcr American Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58605010601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58605-106-01
11-Digit CMS (5-4-2)
58605-0106-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.